Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca, Eli Lilly move closely watched BACE Alzheimer's trial into PhIII
AstraZeneca, Eli Lilly move closely watched BACE Alzheimer's trial into PhIII
AstraZeneca, Eli Lilly move closely watched BACE Alzheimer's trial into PhIII
Submitted by
admin
on April 8, 2016 - 10:59am
Source:
Fierce Biotech
News Tags:
AstraZeneca
Eli Lilly
BACE inhibitors
Alzheimer's disease
AZD3293
Headline:
AstraZeneca, Eli Lilly move closely watched BACE Alzheimer's trial into PhIII
Do Not Allow Advertisers to Use My Personal information
